282 related articles for article (PubMed ID: 17397154)
1. Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging.
Bridot JL; Faure AC; Laurent S; Rivière C; Billotey C; Hiba B; Janier M; Josserand V; Coll JL; Elst LV; Muller R; Roux S; Perriat P; Tillement O
J Am Chem Soc; 2007 Apr; 129(16):5076-84. PubMed ID: 17397154
[TBL] [Abstract][Full Text] [Related]
2. Gadolinium chelate coated gold nanoparticles as contrast agents for both X-ray computed tomography and magnetic resonance imaging.
Alric C; Taleb J; Le Duc G; Mandon C; Billotey C; Le Meur-Herland A; Brochard T; Vocanson F; Janier M; Perriat P; Roux S; Tillement O
J Am Chem Soc; 2008 May; 130(18):5908-15. PubMed ID: 18407638
[TBL] [Abstract][Full Text] [Related]
3. Gadolinium oxide nanoparticles and aptamer-functionalized silver nanoclusters-based multimodal molecular imaging nanoprobe for optical/magnetic resonance cancer cell imaging.
Li J; You J; Dai Y; Shi M; Han C; Xu K
Anal Chem; 2014 Nov; 86(22):11306-11. PubMed ID: 25338209
[TBL] [Abstract][Full Text] [Related]
4. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
[TBL] [Abstract][Full Text] [Related]
5. Comparative study on in vivo behavior of PEGylated gadolinium oxide nanoparticles and Magnevist as MRI contrast agent.
Dai Y; Wu C; Wang S; Li Q; Zhang M; Li J; Xu K
Nanomedicine; 2018 Feb; 14(2):547-555. PubMed ID: 29253637
[TBL] [Abstract][Full Text] [Related]
6. Gastrin-releasing peptide receptor-targeted gadolinium oxide-based multifunctional nanoparticles for dual magnetic resonance/fluorescent molecular imaging of prostate cancer.
Cui D; Lu X; Yan C; Liu X; Hou M; Xia Q; Xu Y; Liu R
Int J Nanomedicine; 2017; 12():6787-6797. PubMed ID: 28979118
[TBL] [Abstract][Full Text] [Related]
7. Physicochemical properties of gadoteridol and other magnetic resonance contrast agents.
Tweedle MF
Invest Radiol; 1992 Aug; 27 Suppl 1():S2-6. PubMed ID: 1506149
[No Abstract] [Full Text] [Related]
8. Tumor-specific design of PEGylated gadolinium-based nanoscale particles: Facile synthesis, characterization, and improved magnetic resonance imaging of metastasis lung cancer.
Sui Y; Li Y; Li Y; Jin H; Zheng Y; Huang W; Chen S
J Photochem Photobiol B; 2020 Jan; 202():111669. PubMed ID: 31739258
[TBL] [Abstract][Full Text] [Related]
9. Engineered magnetic hybrid nanoparticles with enhanced relaxivity for tumor imaging.
Aryal S; Key J; Stigliano C; Ananta JS; Zhong M; Decuzzi P
Biomaterials; 2013 Oct; 34(31):7725-32. PubMed ID: 23871540
[TBL] [Abstract][Full Text] [Related]
10. PEGylated hybrid ytterbia nanoparticles as high-performance diagnostic probes for in vivo magnetic resonance and X-ray computed tomography imaging with low systemic toxicity.
Liu Z; Pu F; Liu J; Jiang L; Yuan Q; Li Z; Ren J; Qu X
Nanoscale; 2013 May; 5(10):4252-61. PubMed ID: 23546530
[TBL] [Abstract][Full Text] [Related]
11. Rapid synthesis of PEGylated ultrasmall gadolinium oxide nanoparticles for cell labeling and tracking with MRI.
Faucher L; Tremblay M; Lagueux J; Gossuin Y; Fortin MA
ACS Appl Mater Interfaces; 2012 Sep; 4(9):4506-15. PubMed ID: 22834680
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution study of nanometric hybrid gadolinium oxide particles as a multimodal SPECT/MR/optical imaging and theragnostic agent.
Kryza D; Taleb J; Janier M; Marmuse L; Miladi I; Bonazza P; Louis C; Perriat P; Roux S; Tillement O; Billotey C
Bioconjug Chem; 2011 Jun; 22(6):1145-52. PubMed ID: 21545181
[TBL] [Abstract][Full Text] [Related]
13. A top-down synthesis route to ultrasmall multifunctional Gd-based silica nanoparticles for theranostic applications.
Mignot A; Truillet C; Lux F; Sancey L; Louis C; Denat F; Boschetti F; Bocher L; Gloter A; Stéphan O; Antoine R; Dugourd P; Luneau D; Novitchi G; Figueiredo LC; de Morais PC; Bonneviot L; Albela B; Ribot F; Van Lokeren L; Déchamps-Olivier I; Chuburu F; Lemercier G; Villiers C; Marche PN; Le Duc G; Roux S; Tillement O; Perriat P
Chemistry; 2013 May; 19(19):6122-36. PubMed ID: 23512788
[TBL] [Abstract][Full Text] [Related]
14. Hydrothermally synthesized PEGylated calcium phosphate nanoparticles incorporating Gd-DTPA for contrast enhanced MRI diagnosis of solid tumors.
Mi P; Kokuryo D; Cabral H; Kumagai M; Nomoto T; Aoki I; Terada Y; Kishimura A; Nishiyama N; Kataoka K
J Control Release; 2014 Jan; 174():63-71. PubMed ID: 24211705
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement.
Ahrén M; Selegård L; Klasson A; Söderlind F; Abrikossova N; Skoglund C; Bengtsson T; Engström M; Käll PO; Uvdal K
Langmuir; 2010 Apr; 26(8):5753-62. PubMed ID: 20334417
[TBL] [Abstract][Full Text] [Related]
16. Physical, chemical and biological evaluations of CMD-A2-Gd-DOTA. A new paramagnetic dextran polymer.
Corot C; Schaefer M; Beauté S; Bourrinet P; Zehaf S; Bénizé V; Sabatou M; Meyer D
Acta Radiol Suppl; 1997; 412():91-9. PubMed ID: 9240087
[TBL] [Abstract][Full Text] [Related]
17. A novel gadolinium-based trimetasphere metallofullerene for application as a magnetic resonance imaging contrast agent.
Adiseshaiah P; Dellinger A; MacFarland D; Stern S; Dobrovolskaia M; Ileva L; Patri AK; Bernardo M; Brooks DB; Zhou Z; McNeil S; Kepley C
Invest Radiol; 2013 Nov; 48(11):745-54. PubMed ID: 23748228
[TBL] [Abstract][Full Text] [Related]
18. Cascade polymeric MRI contrast media derived from poly(ethylene glycol) cores: initial syntheses and characterizations.
Fu Y; Raatschen HJ; Nitecki DE; Wendland MF; Novikov V; Fournier LS; Cyran C; Rogut V; Shames DM; Brasch RC
Biomacromolecules; 2007 May; 8(5):1519-29. PubMed ID: 17402781
[TBL] [Abstract][Full Text] [Related]
19. Preparation and in vivo imaging of PEG-poly(L-lysine)-based polymeric micelle MRI contrast agents.
Shiraishi K; Kawano K; Minowa T; Maitani Y; Yokoyama M
J Control Release; 2009 May; 136(1):14-20. PubMed ID: 19331861
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of macrocyclic gadolinium chelates as hepatospecific MRI agents.
Marinelli ER; Neubeck R; Song B; Wagler T; Ranganathan RS; Sukumaran K; Wedeking P; Nunn A; Runge V; Tweedle M
Acad Radiol; 2002 May; 9 Suppl 1():S251-4. PubMed ID: 12019882
[No Abstract] [Full Text] [Related]
[Next] [New Search]
